Multiple Myeloma and Amyloidosis Clinical Program Archives

A multiple myeloma physician talking with a nurse in the clinic.

March is Multiple Myeloma Awareness Month, an opportunity to shed light on a disease that accounts for approximately 10% of all blood cancers. Treatment options for multiple myeloma have expanded in recent years, leading to better patient outcomes and longer survival rates.

Multiple myeloma is cancer of the immune system. Oncologist Sascha Tuchman, MD, MHS, shares what you need to know about the condition and treatment.

Shakira Grant, MBBS, the studies’ principal investigator, shared the findings during oral presentations at the annual meeting of the American Society of Hematology (ASH) in New Orleans.

A study led by UNC Lineberger's Shakira Grant, MBBS, and colleagues found several barriers to high-quality cancer care for people with multiple myeloma and their caregivers.

Sascha Tuchman uses a stethoscope on a patient's back

Sascha Tuchman, MD, MHS, specializes in hematology, and specifically multiple myeloma and amyloidosis. At UNC Lineberger, he collaborates with other UNC Lineberger clinicians and scientists, and works to cultivate the next generation of myeloma experts.

UNC Lineberger’s Shakira Grant, MBBS, was awarded a two-year research grant to study the illness and treatment experiences of older adults with multiple myeloma and their care partners.

Tag: Multiple Myeloma and Amyloidosis Clinical Program

Improved multiple myeloma therapies help patients live longer, better lives

CURE: Tracking a Mystery in Non-Secretory Myeloma

Multiple myeloma is a silent invader

Oncology: Recap: MRD Negativity, Frailty, and Emerging Therapies in Multiple Myeloma

ASCO Post: Studies Focusing on Age- and Race-Related Disparities in Multiple Myeloma and Sickle Cell Disease

Studies identify barriers between doctors and their patients that limit clinical trial enrollment for Black people with blood cancers

Study identifies health care access barriers for older adults with multiple myeloma and their caregivers

CancerNetwork: Evaluating MRD-Guided Therapy in Patients with NDMM

Hematologist focuses on multiple myeloma, amyloidosis

Grant receives $200,000 NIH grant to study impact of multiple myeloma on older adults, care partners